2023-07-11 08:20:47 ET
- Viridian Therapeutics VRDN -19% following thyroid eye disease asset data .
- ADC Therapeutics ( ADCT ) -16% announces voluntary pause of enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA and Rituximab in unfit or frail previously untreated DLBCL patients
- Iovance Biotherapeutics IOVA -12% on pricing $150M stock offering .
- Anixa Biosciences ( ANIX ) -10% .
- American Rebel Holdings ( AREB ) -11% .
- Journey Medical ( DERM ) -9% .
- Alpine 4 Holdings ( ALPP ) -8% .
- Ryvyl ( RVYL ) -7% .
- Equitrans Midstream ETRN -7% as court blocks Mountain Valley pipeline construction in Jefferson National Forest.
- Infobird ( IFBD ) -6% .
- Lux Vending ( BTM ) -5% .
For further details see:
ALPN, ANIX and ADCT among pre-market losers